Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Misjudgement of gefitinib efficacy in patients with central non-small-cell lung cancer due to obstructive atelectasis caused by stereotactic radiotherapy.

Yang X, Xiong Y, Huang H, Peng B, Zhou Z, Xu M, Yang Y, Wang D.

Mol Clin Oncol. 2014 Jul;2(4):535-538. Epub 2014 Apr 30.

2.

Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.

Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1432-41. Epub 2005 Aug 25.

PMID:
16125870
4.

Stereotactic body radiotherapy for medically inoperable lung cancer: prospective, single-center study of 108 consecutive patients.

Taremi M, Hope A, Dahele M, Pearson S, Fung S, Purdie T, Brade A, Cho J, Sun A, Bissonnette JP, Bezjak A.

Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):967-73. doi: 10.1016/j.ijrobp.2010.12.039. Epub 2011 Mar 4.

PMID:
21377293
5.

Stereotactic radiotherapy (SBRT) as a sole or salvage therapy in non-small cell lung cancer patients.

Dworzecki T, Idasiak A, Syguła D, Dworzecka U, Suwiński R.

Neoplasma. 2012;59(1):114-20.

PMID:
22103905
6.

Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer Center.

Rosen LR, Fischer-Valuck BW, Katz SR, Durci M, Wu HT, Syh J, Syh J, Patel B.

Tumori. 2014 Jan-Feb;100(1):42-8. doi: 10.1700/1430.15814.

PMID:
24675490
7.

Fractionated stereotactic body radiation therapy in the treatment of primary, recurrent, and metastatic lung tumors: the role of positron emission tomography/computed tomography-based treatment planning.

Coon D, Gokhale AS, Burton SA, Heron DE, Ozhasoglu C, Christie N.

Clin Lung Cancer. 2008 Jul;9(4):217-21. doi: 10.3816/CLC.2008.n.032.

PMID:
18650169
8.

Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer.

Bradley J, Thorstad WL, Mutic S, Miller TR, Dehdashti F, Siegel BA, Bosch W, Bertrand RJ.

Int J Radiat Oncol Biol Phys. 2004 May 1;59(1):78-86.

PMID:
15093902
9.

Stereotactic body radiotherapy for central lung tumors.

Rowe BP, Boffa DJ, Wilson LD, Kim AW, Detterbeck FC, Decker RH.

J Thorac Oncol. 2012 Sep;7(9):1394-9. doi: 10.1097/JTO.0b013e3182614bf3.

PMID:
22843088
10.

Stereotactic hypofractionated radiation therapy for stage I non-small cell lung cancer.

Zimmermann FB, Geinitz H, Schill S, Grosu A, Schratzenstaller U, Molls M, Jeremic B.

Lung Cancer. 2005 Apr;48(1):107-14. Epub 2004 Dec 19.

PMID:
15777977
11.

[Impact of computed tomography (CT) and 18F-deoxyglucose-coincidence detection emission tomography (FDG-CDET) image fusion for optimisation of conformal radiotherapy in non-small-cell lung cancers].

Deniaud-Alexandre E, Touboul E, Lerouge D, Grahek D, Foulquier JN, Petegnief Y, Grès B, El Balaa H, Keraudy K, Kerrou K, Montravers F, Milleron B, Lebeau B, Talbot JN.

Cancer Radiother. 2005 Sep;9(5):304-15. Epub 2005 Aug 8. French.

PMID:
16087377
12.

Is there a lower limit of pretreatment pulmonary function for safe and effective stereotactic body radiotherapy for early-stage non-small cell lung cancer?

Guckenberger M, Kestin LL, Hope AJ, Belderbos J, Werner-Wasik M, Yan D, Sonke JJ, Bissonnette JP, Wilbert J, Xiao Y, Grills IS.

J Thorac Oncol. 2012 Mar;7(3):542-51. doi: 10.1097/JTO.0b013e31824165d7.

PMID:
22258475
13.

Stereotactic body radiation therapy of lung tumors: preliminary experience using normal tissue complication probability-based dose limits.

Song DY, Benedict SH, Cardinale RM, Chung TD, Chang MG, Schmidt-Ullrich RK.

Am J Clin Oncol. 2005 Dec;28(6):591-6.

PMID:
16317270
14.

Dose as a function of lung volume and planned treatment volume in helical tomotherapy intensity-modulated radiation therapy-based stereotactic body radiation therapy for small lung tumors.

Baisden JM, Romney DA, Reish AG, Cai J, Sheng K, Jones DR, Benedict SH, Read PW, Larner JM.

Int J Radiat Oncol Biol Phys. 2007 Jul 15;68(4):1229-37. Epub 2007 May 21.

PMID:
17513066
15.
16.

Evaluation for local failure by 18F-FDG PET/CT in comparison with CT findings after stereotactic body radiotherapy (SBRT) for localized non-small-cell lung cancer.

Takeda A, Kunieda E, Fujii H, Yokosuka N, Aoki Y, Oooka Y, Oku Y, Ohashi T, Sanuki N, Mizuno T, Ozawa Y.

Lung Cancer. 2013 Mar;79(3):248-53. doi: 10.1016/j.lungcan.2012.11.008. Epub 2012 Dec 11.

PMID:
23246123
17.

Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer.

Trovo M, Minatel E, Durofil E, Polesel J, Avanzo M, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Rumeileh IA, Trovo MG.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1114-9. doi: 10.1016/j.ijrobp.2014.01.012.

PMID:
24661664
18.
19.

[An analysis of 20 consecutive patients treated with stereotactic body radiotherapy on Novalis Tx(®) for stage I non-small-cell lung cancer].

Guillerme F, Clavier JB, Schumacher C, Falcoz PE, Bourrhala K, Santelmo N, Hassler S, Schott R, Quoix E, Massard G, Noël G.

Cancer Radiother. 2013 Jul-Aug;17(4):272-81. doi: 10.1016/j.canrad.2013.01.021. Epub 2013 May 24. French.

PMID:
23712043
20.

Stereotactic body radiation therapy for early stage non-small cell lung cancer: results of a prospective trial.

Ricardi U, Filippi AR, Guarneri A, Giglioli FR, Ciammella P, Franco P, Mantovani C, Borasio P, Scagliotti GV, Ragona R.

Lung Cancer. 2010 Apr;68(1):72-7. doi: 10.1016/j.lungcan.2009.05.007. Epub 2009 Jun 24.

PMID:
19556022
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk